2026 NPPES data Gynecologic Oncology Physician NPI 1396024600 MD, MPP
Verify on CMS →

EIJEAN WU, MD, MPP

Gynecologic Oncology Physician in LOS ANGELES, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
197
Medicare Part D claims · 73 beneficiaries · Gynecologic Oncology Physician avg: 188
Generic prescribing
84%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.1 · [object Object]
Industry payments
$4.0K
48 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

EIJEAN WU, MD, MPP reported a CMS MIPS final score of 100/100 — above the 83.1 national average — and filed 197 Medicare Part D claims in 2023.

100/100
MIPS score · +17 vs avg
197
Part D claims, 2023
84%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

EIJEAN WU, MD, MPP's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

100 Top 7% higher than 93% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

EIJEAN WU, MD, MPP practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about EIJEAN WU, MD, MPP?

High performer (top quartile)

NPI registry status

Active

Issued 08/04/2011

NPI 1396024600

Primary specialty

Gynecologic Oncology Physician

Niche

1,360 US NPIs in this specialty

Medicare Part D claims

197 5% vs specialty avg

2023 prescription claims

Specialty avg: 188

MIPS final score

100/100 16.900000000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in California

How Gynecologic Oncology Physician compares to other specialties among California providers

California providers

Gynecologic Oncology Physician share within California

1. Gynecologic Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Gynecologic Oncology Physician share within California

Medicare quality performance — MIPS

EIJEAN WU, MD, MPP's 2023 MIPS final score plotted against the Gynecologic Oncology Physician national average

High performer (top quartile)
MIPS Final Score
100/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Gynecologic Oncology Physician) — 100/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Gynecologic Oncology Physician) — 100/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

EIJEAN WU, MD, MPP is a Gynecologic Oncology Physician provider practicing in LOS ANGELES, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD, MPP. NPI: 1396024600. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

EIJEAN WU, MD, MPP appears in the CMS NPPES registry as a Gynecologic Oncology Physician provider holding MD, MPP credentials at 1300 N VERMONT AVE STE 1001, LOS ANGELES, CA, 90027, with a listed phone of (323) 473-5499. NPI 1396024600 was issued on 08/04/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WU most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 197 prescription claims written by this provider, covering 73 Medicare beneficiaries and totaling roughly $354K in drug spend, split 16% brand-name and 84% generic by claim count, with an opioid prescribing rate of 16.8%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year, compared with the national average of 83.1.

Gynecologic Oncology Physician is a narrow specialty nationwide, with 1,360 enrolled providers across 49 states and an average of 188 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1300 N VERMONT AVE STE 1001
LOS ANGELES, CA 90027

Provider Details

NPI 1396024600
Specialty Gynecologic Oncology Physician
Credentials MD, MPP
Gender Female
NPI Issued 08/04/2011

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

100
Final Score
Avg: 83.1
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where EIJEAN WU, MD, MPP bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

BASS MEDICAL GROUP
LOS ANGELES, CA
WHITE MEMORIAL GYNECOLOGICAL AND OBSTETRICAL MEDICAL GROUP
LOS ANGELES, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for EIJEAN WU, MD, MPP. Source: openpaymentsdata.cms.gov.

Total received

$4.0K

Largest payer

PFIZER INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to EIJEAN WU, MD, MPP. To verify EIJEAN WU, MD, MPP's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

EIJEAN WU, MD, MPP — brand share 16.0%
Specialty average (est.)

16% brand-name claims vs 84% generic, on 197 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

197
Total Claims
$354K
Total Drug Cost
73
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
252
Total Day Supply
5,724
Brand vs Generic
16% brand / 84% generic
Brand Drug Cost
$349K
Generic Drug Cost
$5K
Opioid Claims
33 (16.8% rate)

Patient Demographics

Average Patient Age
70.8 years
Avg HCC Risk Score
1.71
Gender Split
100% female / 0% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Tramadol Hcl
31
Estradiol
22
Lynparza
Olaparib
15
Nystatin
15

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Gynecologic Oncology Physician Overview

How EIJEAN WU, MD, MPP fits within the Gynecologic Oncology Physician landscape nationally.

1,360
Gynecologic Oncology Physician Providers in US
49
States with Gynecologic Oncology Physician
188
Avg Claims per Provider

EIJEAN WU, MD, MPP's 197 claims are above the specialty average of 188.

Nearby Gynecologic Oncology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as WU.

Compare Gynecologic Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is EIJEAN WU, MD, MPP's specialty?
EIJEAN WU, MD, MPP specializes in Gynecologic Oncology Physician and practices in LOS ANGELES, California. Credentials: MD, MPP.
How much does EIJEAN WU, MD, MPP prescribe under Medicare Part D?
In 2023, EIJEAN WU, MD, MPP wrote 197 Medicare Part D claims totaling $354K in drug costs for 73 beneficiaries.
What is EIJEAN WU, MD, MPP's Medicare quality score?
EIJEAN WU, MD, MPP has a CMS MIPS Final Score of 100/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is EIJEAN WU, MD, MPP located?
EIJEAN WU, MD, MPP is located at 1300 N VERMONT AVE STE 1001, LOS ANGELES, CA, 90027. Phone: (323) 473-5499.
What is EIJEAN WU, MD, MPP's NPI number?
EIJEAN WU, MD, MPP's National Provider Identifier (NPI) is 1396024600, issued on 08/04/2011.
Does EIJEAN WU, MD, MPP prescribe more brand-name or generic drugs?
EIJEAN WU, MD, MPP's prescribing is 16% brand-name and 84% generic drugs by claim count, with $349K in brand drug costs.
Does EIJEAN WU, MD, MPP prescribe opioids?
Yes, EIJEAN WU, MD, MPP had 33 opioid claims in 2023 with an opioid prescribing rate of 16.8%.
How many Gynecologic Oncology Physician providers are there in the US?
There are 1,360 Gynecologic Oncology Physician providers across 49 states in the US. The average Gynecologic Oncology Physician provider writes 188 Medicare Part D claims per year.
What drugs does EIJEAN WU, MD, MPP prescribe most often?
Based on 2023 Medicare Part D data, EIJEAN WU, MD, MPP's most frequently prescribed drugs include Tramadol Hcl, Estradiol, Lynparza. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does EIJEAN WU, MD, MPP accept Medicare?
EIJEAN WU, MD, MPP appears in CMS Medicare data with 197 Part D claims and 73 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify EIJEAN WU, MD, MPP's credentials?
EIJEAN WU, MD, MPP's NPI is 1396024600 with credentials MD, MPP. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology